WebCura Therapeutics is developing innovative immunotherapies to cure cancer and infectious diseases. Our technologies harness cytokines to create multi-functional proteins with … WebApr 15, 2024 · Kura Oncology (NASDAQ:KURA – Get Rating) last issued its quarterly earnings results on Thursday, February 23rd. The company reported ($0.49) EPS for the …
Where Will Kura Oncology Inc (KURA) Stock Go Next
WebOct 18, 2024 · In addition, Kura is pursuing the use of tipifarnib in combination with other oncology therapeutics to address larger genetic subsets of patients, including those who have HRAS- and/or PIK3CA ... WebMar 15, 2024 · Two Late-Stage Therapeutics for Multiple Oncology Indications with Unmet Medical Needs. VAL-083 is a structurally-unique small molecule targeting DNA to inhibit cancer cell replication and cell division, which leads to cell death. Like other established agents extensively studied by U.S. National Cancer Institute (NCI), such as cisplatin ... bruce crowley provincetown
Where Will Kura Oncology Inc (KURA) Stock Go Next
WebAug 5, 2024 · Collins joins with more than 25 years of medical experience, most recently as Chief Medical Officer at Five Prime Therapeutics, ... Kura’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT today, August 5, 2024, to discuss the financial results for the second quarter 2024 and provide a corporate update. The ... WebAug 7, 2024 · Kura Oncology Inc is a clinical-stage biopharmaceutical company, engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. WebKura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. bruce cruickshank